The growth of the Preimplantation Genetic Testing market is driven by increasing demand for in vitro fertilization (IVF) treatments and rising awareness of genetic disorders. Technological advancements in genetic screening are enhancing the accuracy of detecting chromosomal abnormalities, boosting the adoption of PGT. Additionally, growing acceptance of IVF procedures and the desire to minimize the risk of inherited diseases among parents are further contributing to market expansion.
LEWES, Del. , Nov. 19, 2024 /PRNewswire/ -- The global Preimplantation Genetic Testing market is projected to grow from approximately USD 0.
67 billion in 2024 to USD 1.2 billion by 2031, at a compound annual growth rate (CAGR) of around 8%. This growth is driven by increasing demand for IVF procedures, advancements in genetic testing technologies, and rising awareness of hereditary genetic disorders.
Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=204253 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Preimplantation Genetic Testing Market Overview 1.
Market Definition and Scope Preimplantation Genetic Testing is a screening procedure used in conjunction with in vitro fertilization (IVF) to assess embryos for genetic abnormalities before implantation. The primary aim is to identify chromosomal disorders, single gene mutations, and inherited diseases that could lead to miscarriage or birth defects. As demand for assisted reproductive technologies (.
